Research & News
AIDSinfo Releases Brief Versions of HIV/AIDS Practice Guidelines
Nov 14, 2018
AIDSinfo recently announced the release of brief versions of the federally approved HIV/AIDS medical practice guidelines. Health care providers had requested shorter versions of the guidelines that are easier to use at the point of care. AIDSinfo used this feedback to... Read More
Intimate Partner Violence and HIV Care in Pregnancy
Nov 09, 2018
In this article, the authors describe the relationship between intimate partner violence (IPV) and ARV adherence and viral suppression in pregnancy. They conclude that IPV during a pregnancy is associated with decreased ARV adherence and delays in achieving virologic... Read More
Stigma and the Elimination of Perinatal HIV in the U.S.
Nov 09, 2018
In this article, the authors describe the relationship between stigma toward pregnant women with HIV and efforts to eradicate perinatal HIV transmission. They conclude that stigma plays a significant role in the inability of the U.S. to eliminate MTCT of HIV.
Citation... Read More
Perinatal HIV Service Coordination
Aug 17, 2018
In this article, the authors describe a comprehensive concept of perinatal HIV service coordination. The authors identify six core functions to close the gap in the HIV care continuum for pregnant women and prevent perinatal transmission of HIV in the United States.... Read More
HIV-Specific Prenatal Classes to Begin in September
Aug 17, 2018
The next series of PACPI's HIV-specific prenatal classes have been scheduled to begin September 11, 2018. Please see the attached flyer for the class and call 312-334-0971 to enroll your clients and patients.
PACPI Hiring Perinatal Analyst for Repeat Third Trimester Testing Support
Jun 08, 2018
The Pediatric AIDS Chicago Prevention Initiative (PACPI) is hiring a Perinatal Analyst to support the implementation of repeat third trimester HIV testing of pregnant women in Illinois hospitals as funded by the Illinois Department of Public Health. This is a part-time... Read More
Potential Risk of Neural Tube Birth Defects With Dolutegravir
May 29, 2018
The U.S. Food and Drug Administration (FDA) is alerting the public that serious cases of neural tube birth defects involving the brain, spine, and spinal cord have been reported in babies born to women treated with dolutegravir used to treat human immunodeficiency virus (... Read More
Next Series of HIV-Specific Prenatal Classes to Begin June 2018
May 29, 2018
The next series of PACPI's HIV-specific prenatal classes have been scheduled to begin June 15, 2018. Please see the attached flyer for the class and call 312-334-0971 to enroll your clients and patients.
Birth Outcomes for Pregnant Women Using Tenofovir-Emtricitabine
May 29, 2018
In a previous trial of antiretroviral therapy involving pregnant women with HIV infection, those randomly assigned to receive tenofovir, emtricitabine, and ritonavir-boosted lopinavir (TDF-FTC-LPV/r) had infants at greater risk for very premature birth and death within 14... Read More
Risk of Acquiring HIV Increases During and After Pregnancy
Mar 09, 2018
New research suggests a woman’s risk of acquiring HIV through sex with a male partner living with HIV increases during pregnancy and is highest during the postpartum period. Click here to read more about this research presented at the 2018 CROI Conference.
